Cancer Cell Biology and Genetics To Collaborate Scientific Professionals around the World Conference DateSeptember 21-22, 2023 For Sponsors & Exhibitors sponsor@conferenceseries.com Speaker Opportunity Poster OpportunityE-Poster Opportunity Useful Links ...
Geneticists: Delve into genetic mutations,oncogenes, and genome-wide studies, and discover the role of genetics in personalized cancer treatment. Immunologists: Learn about advancements inimmunotherapies, immune checkpoint inhibitors, and how the immune system can be harnessed to fight cancer. ...
Oncology Conference-Submit Abstract Now!! - International Conference on Oncology and Cancer Research by Oncology Conferences 2024, Pencis
International Crop Science Conference & Exhibition EnviroTech Athens 2025 EDULEARN 25 - The 17th annual International Conference on Education and New Learning Technologies Articles / News / Press releases Cancer Basic Research New Trends of Warthin Tumor Management: A Systematic Review of Non-Surgical ...
Cancer Genetics and Epigenetics Cancer Diagnosis and Staging Radiation Oncology Neuro Oncology Thoracic Oncology Psychosocial Oncology Molecular Cancer Biology Tumor Markers and Signatures Hematologic Malignancy Translational oncology Other Key Topics Submit Abstract ...
Track 12: Cancer Pathology & Genetics Cancer is a disease engage in abnormal cell growth with the capability to invade or spread to other parts of the body. All tumors are not cancerous, benign tumors do not spread to other parts of the body. Neoplasm is an abnormal growth of tissue, wh...
Age and genetics are the primary factors influencing breast cancer risk, with the majority of cases occurring in women over 50. Hereditary conditions such as BRCA1 and BRCA2 mutations increase the risk, and environmental factors, including lifestyle choices and occupational exposures, also play a ...
Cancer Genetics Radiation Oncology Chemotherapy CAR T Cell Therapy Radiation Oncology & Cancer Tumor Molecular Epidemiology Anti-Cancer Drug Discovery & Therapy Cancer Prevention & Research Submit Abstract Be a part of Cancer Science 2025 to Global Excellence Excellent Speakers Parallel Events ...
December 13th 2024 Patients with high-risk, HR-positive, HER2-negative breast cancer treated with HER3-DXd with or without Femara (letrozole) experienced fewer side effects than with chemotherapy. Read More Understanding Genetics May Predict Treatment Response in Triple-Negative Breast Cancer Jordyn Sa...
Chemistry EEE & Engineering Environmental Sciences Genetics & Molecular Biology Geology & Earth science Hematology Materials Science Nanotechnology Nephrology Nutrition Petroleum Pharma Marketing & Industry Pharmaceutical Sciences Physics Pulmonology Veterinary...